Solutions to improve COVID-19 vaccine access & protect intellectual property

On behalf of the patients we serve who are living with HIV, hepatitis, cancer, lupus, autoimmune diseases, and other serious chronic and complex conditions, we write to share recommendations to address global COVID-19 vaccine equity and access barriers. While we commend the World Trade Organization (WTO) and the Office of the United States Trade Representative for prioritizing efforts to improve vaccine access, it must not come at the expense of waiving intellectual property (IP) protections.  To do so would have unprecedented effects on future medical development.

read more

Pin It on Pinterest